10 completed, 3 unknown, 1 withdrawn. 14 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 10, Unknown 3, Withdrawn 1 |
Follow Metrorrhagia: new trials by email Literature Review of Metrorrhagia trials Research Report on Metrorrhagia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies Tranexamic Acid, Placebos - Fibroid Uterus, Abnormal Uterine Bleeding | Phase 3 | Unknown | Eastern Virginia Medical School | 50 | 2020-06-20 | 2023-09-11 |
| Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature . norethisterone acetate, tranexamic acid tablets - Dysfunctional Uterine Bleeding | Phase 3 | Unknown | Cairo University | 120 | 2020-04-22 | 2020-03-16 |
| Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB Desogestrel, Medroxyprogesterone acetate - Dysfunctional Uterine Bleeding | Phase 3 | Unknown | Mahidol University | 160 | 2013-08-01 | 2018-08-22 |
| Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol barrier methods - Metrorrhagia | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2013-07-01 | 2017-09-21 | |
| Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding EV/DNG (Qlaira, Natazia, BAY86-5027), placebo - Metrorrhagia | Phase 3 | Completed | Bayer | 339 | 2012-06-01 | 2015-07-10 |
| Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo - Metrorrhagia | Phase 3 | Completed | Bayer | 231 | 2006-02-01 | 2014-12-30 |
| Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo - Metrorrhagia | Phase 3 | Completed | Bayer | 190 | 2005-12-01 | 2013-11-27 |
| Study of Asoprisnil in the Treatment of Uterine Fibroids. Asoprisnil - Fibroid Uterus, Leiomyoma | Phase 3 | Completed | Abbott | 149 | 2004-11-01 | 2008-05-28 |
| Safety of Treatment of Uterine Fibroids With Asoprisnil Asoprisnil - Fibroid Uterus, Leiomyoma | Phase 3 | Completed | Abbott | 166 | 2004-04-01 | 2008-05-29 |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids Asoprisnil, Placebo - Fibroid Uterus, Leiomyoma | Phase 3 | Completed | Abbott | 239 | 2003-09-01 | 2008-05-29 |
| Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Asoprisnil - Leiomyoma, Menorrhagia | Phase 3 | Completed | Abbott | 523 | 2003-09-01 | 2008-05-29 |
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids Asoprisnil, Placebo - Leiomyoma, Menorrhagia | Phase 3 | Completed | Abbott | 432 | 2002-09-01 | 2008-05-29 |
| Treatment of Uterine Fibroids With Asoprisnil(J867) Asoprisnil, Placebo - Leiomyoma, Menorrhagia | Phase 3 | Completed | Abbott | 475 | 2002-07-01 | 2008-05-29 |
| Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) hysterectomy, endometrial ablation - Menorrhagia, Uterine Bleeding | Phase 3 | Completed | Agency for Healthcare Research and Quality (AHRQ) | 242 | 1997-11-01 | 2005-06-24 |
Menorrhagia (8) · Leiomyoma (7) · Uterine Hemorrhage (7) · Myofibroma (1)
Female Urogenital Diseases (14) · Female Urogenital Diseases and Pregnancy Complications (14) · Genital Diseases (14) · Genital Diseases, Female (14) · Hemorrhage (14) · Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Urogenital Diseases (14) · Uterine Diseases (14) · Menstruation Disturbances (8) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Neoplasms, Connective and Soft Tissue (7) · Neoplasms, Muscle Tissue (7) · Uterine Hemorrhage (7)
asoprisnil (6) · Estradiol (2) · Tranexamic Acid (2) · dienogest (2) · Contraception, Barrier (1) · Desogestrel (1) · Endometrial Ablation Techniques (1) · Hysterectomy (1) · Medroxyprogesterone Acetate (1) · Norethindrone Acetate (1)
Abbott (6) · Bayer (3) · Agency for Healthcare Research and Quality (AHRQ) (1) · Cairo University (1) · Eastern Virginia Medical School (1) · Eurofarma Laboratorios S.A. (1) · Mahidol University (1)
Thailand (2) · United States (2) · Australia (1) · Brazil (1) · Canada (1) · China (1) · Czechia (1) · Finland (1) · Germany (1) · Hungary (1) · Netherlands (1) · Philippines (1) · Poland (1) · Russia (1) · Singapore (1)
Kay Dickersin, PhD (1) · Manee Rattanachaiyanont, M.D. (1) · Seifeldin Sadek, MD (1)
PMID 21774563, PMID 22240178, PMID 23188490, PMID 30865281, PMID 18055721, PMID 19111789, PMID 21422847, PMID 21784734, PMID 22927764, PMID 23439617, PMID 31777761, PMID 35102226
2005 (1)